Shudong Wang

5.4k total citations
143 papers, 4.0k citations indexed

About

Shudong Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shudong Wang has authored 143 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 55 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shudong Wang's work include Cancer-related Molecular Pathways (43 papers), Advanced Breast Cancer Therapies (21 papers) and Protein Degradation and Inhibitors (20 papers). Shudong Wang is often cited by papers focused on Cancer-related Molecular Pathways (43 papers), Advanced Breast Cancer Therapies (21 papers) and Protein Degradation and Inhibitors (20 papers). Shudong Wang collaborates with scholars based in Australia, China and United Kingdom. Shudong Wang's co-authors include Mingfeng Yu, Solomon Tadesse, Peter M. Fischer, Frankie Lam, Malika Kumarasiri, Theodosia Teo, Wayne D. Tilley, Robert Milne, Hugo Albrecht and Sarah Diab and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Shudong Wang

137 papers receiving 3.9k citations

Peers

Shudong Wang
Dajun Yang China
Christopher L. Morton United States
Peter L. Toogood United States
Taebo Sim South Korea
Wilbur R. Leopold United States
Tinghu Zhang United States
A. Chaikuad Germany
Uwe Rix United States
Alan J. Kraker United States
Edgar R. Wood United States
Dajun Yang China
Shudong Wang
Citations per year, relative to Shudong Wang Shudong Wang (= 1×) peers Dajun Yang

Countries citing papers authored by Shudong Wang

Since Specialization
Citations

This map shows the geographic impact of Shudong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shudong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shudong Wang more than expected).

Fields of papers citing papers by Shudong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shudong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shudong Wang. The network helps show where Shudong Wang may publish in the future.

Co-authorship network of co-authors of Shudong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shudong Wang. A scholar is included among the top collaborators of Shudong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shudong Wang. Shudong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mekonnen, Laychiluh, Theodosia Teo, Benjamin Noll, et al.. (2025). A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma. Biomedicine & Pharmacotherapy. 189. 118340–118340.
2.
Yu, Mingfeng, et al.. (2023). Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition. Cancers. 15(4). 1044–1044. 3 indexed citations
3.
Laven‐Law, Geraldine, Van T.M. Nguyen, Simak Ali, et al.. (2023). Selective inhibition of CDK9 in triple negative breast cancer. Oncogene. 43(3). 202–215. 10 indexed citations
4.
Teo, Theodosia, Laychiluh Mekonnen, Yuchao Yang, et al.. (2023). Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation. Molecules. 28(7). 2951–2951. 6 indexed citations
5.
Anshabo, Abel Tesfaye, Sarah Diab, Long Yi, et al.. (2022). An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers. 14(5). 1113–1113. 10 indexed citations
6.
Emran, Abdullah Al, Hsin‐Yi Tseng, Dilini Gunatilake, et al.. (2021). A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma. Journal of Investigative Dermatology. 141(9). 2238–2249.e12. 10 indexed citations
7.
Yu, Mingfeng, Long Yi, Yuchao Yang, et al.. (2021). Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation. European Journal of Medicinal Chemistry. 218. 113391–113391. 9 indexed citations
8.
Yu, Mingfeng, Theodosia Teo, Yuchao Yang, et al.. (2021). Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry. 214. 113248–113248. 14 indexed citations
9.
Yi, Long, et al.. (2021). Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations. European Journal of Medicinal Chemistry. 213. 113215–113215. 10 indexed citations
10.
Diab, Sarah, Mingfeng Yu, & Shudong Wang. (2020). CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?. Journal of Medicinal Chemistry. 63(14). 7458–7474. 56 indexed citations
11.
Gao, Xin, Wei Zheng, Xinyu Wen, et al.. (2019). Exploration of bladder cancer-associated methylated miRNAs by methylated DNA immunoprecipitation sequencing. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Tadesse, Solomon, Malika Kumarasiri, Sunita K. C. Basnet, et al.. (2019). Discovery of CDK5 Inhibitors through Structure-Guided Approach. ACS Medicinal Chemistry Letters. 10(5). 786–791. 21 indexed citations
13.
Wang, Rui, et al.. (2019). Genetic analysis of traits of cross progenies of asiatic hybrid lily.. Shenyang Nongye Daxue xuebao. 50(5). 522–528. 1 indexed citations
14.
Zheng, Huiyuan, C. Zhou, Xiao Lu, et al.. (2018). DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1α expression through the PI3K-AKT pathway. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Yu, Mingfeng, Sunita K. C. Basnet, Malika Kumarasiri, et al.. (2015). Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry. 95. 116–126. 31 indexed citations
16.
Teo, Theodosia, Yuchao Yang, Mingfeng Yu, et al.. (2015). An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis. European Journal of Medicinal Chemistry. 103. 539–550. 23 indexed citations
17.
Wang, Shudong. (2011). Nutritional and Safety Evaluation of Unearthed Bamboo Shoots during Growth. Food Science. 1 indexed citations
18.
Ma, Fangfang, et al.. (2008). DNA computing model for shortest directed path problem based on sticker and delete system. Computer Engineering and Applications Journal. 44(25). 40–42. 2 indexed citations
19.
Wang, Shudong, et al.. (2004). Inhibitory Effects of Kojic Acid on Phenoloxidase of Diamondback Moth Plutella xylostella. Zhongguo nongye Kexue. 37(9). 1316–1321. 4 indexed citations
20.
Wang, Shudong, et al.. (2003). Theory and System Analysis on the DNA Computing. Computer Engineering and Applications Journal. 39(9). 70–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dajun Yang Breakdown of academic impact, for papers by Christopher L. Morton Breakdown of academic impact, for papers by Peter L. Toogood Breakdown of academic impact, for papers by Taebo Sim Breakdown of academic impact, for papers by Wilbur R. Leopold Breakdown of academic impact, for papers by Tinghu Zhang Breakdown of academic impact, for papers by A. Chaikuad Breakdown of academic impact, for papers by Uwe Rix Breakdown of academic impact, for papers by Alan J. Kraker Breakdown of academic impact, for papers by Edgar R. Wood
Rankless by CCL
2026